The Medical Letter on Drugs and Therapeutics
June 16, 2008
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
A Fixed-Dose Combination of Sumatriptan and Naproxen for Migraine
June 16, 2008 (Issue: 1288)The FDA has approved an oral, fixed-dose combination (Treximet - GlaxoSmithKline) of the selective serotonin receptor agonist ("triptan") sumatriptan (Imitrex) and the nonsteroidal anti-inflammatory drug (NSAID) naproxen sodium (Anaprox, and others)...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.